December 05, 2022
- Specimen Stability Considerations During Flow Cytometry Assay Development, Optimization and Validation
- Fluorescent Cell Barcoding Using Flow Cytometry For High Throughput Testing
- Flow Cytometry Processing and Analysis of Tumor Specimens: Testing Viability and Staining Post Shipping
- The Importance of Conducting PDX Oncology Studies in a Humanized Immune System
- Leveraging Flow Cytometry to Drive Better Patient Outcomes in Hematologic Malignancy Clinical Trials
Specimen Stability Considerations During Flow Cytometry Assay Development, Optimization and Validation
By Jennifer J. Stewart, PhD
Fluorescent Cell Barcoding Using Flow Cytometry For High Throughput Testing
By Rubina Pal, PhD, Flow Cytometry Scientist
Flow Cytometry Processing and Analysis of Tumor Specimens: Testing Viability and Staining Post Shipping
By Hillary Reif, Administrative Assistant/Research Associate I and Christine Samuelson, Administrative Assistant
Get Started
Contact Us Today!
If you’re looking for an expert team to guide your trial with efficiency in mind, we can help. As the creators of the Dynamic Trial, TD2 provides start-to-finish support with trial strategy, design and execution for faster go-to-market potential.
